| Name | Peroxiredoxin-2 | ||
| UniProt ID | PRDX2_HUMAN | ||
| Gene Name | PRDX2 | ||
| Gene ID | 7001 | ||
| Synonyms |
PRDX2, HEL-S-2a, NKEF-B, NKEFB, PRP, PRX2, PRXII, PTX1, TDPX1, TPX1, TSA
|
||
| Sequence |
MASGNARIGKPAPDFKATAVVDGAFKEVKLSDYKGKYVVLFFYPLDFTFVCPTEIIAFSN
RAEDFRKLGCEVLGVSVDSQFTHLAWINTPRKEGGLGPLNIPLLADVTRRLSEDYGVLKT DEGIAYRGLFIIDGKGVLRQITVNDLPVGRSVDEALRLVQAFQYTDEHGEVCPAGWKPGS DTIKPNVDDSKEYFSKHN |
||
| Pathway Map | MAP LINK | ||
| KEGG ID | hsa7001 | ||
| Pfam | PF00578; PF02630; PF08534; PF10417 | ||
| Pair Name | Dihydroartemisinin, Oxaliplatin | |||
| Phytochemical | Dihydroartemisinin | |||
| Drug | Oxaliplatin | |||
| Disease Info | [ICD-11: 2B91.Z] | Colorectal cancer | Investigative | |
| Regulate Info | Down-regulation | Peroxiredoxin-2 | Expression | |
| Result | We demonstrated an improved therapeutic strategy for CRC patients by combining DHA and oxaliplatin treatments. | |||
